Financials in USD. Standardized financial statements.
A compact view of how BioPorto A/S turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $40.20M | $36.24M | $30.96M | $28.97M | $24.25M | $23.20M | $26.62M | $26.02M | $25.16M | $20.72M |
| Revenue Growth? | +10.9% | +17.1% | +6.9% | +19.4% | +4.5% | -12.8% | +2.3% | +3.4% | +21.4% | 0.0% |
| Cost of Revenue? | $12.25M | $11.71M | $10.78M | $9.93M | $9.21M | $9.87M | $9.29M | $8.18M | $6.91M | $5.03M |
| Gross Profit? | $27.95M | $24.53M | $20.18M | $19.04M | $15.04M | $13.34M | $17.33M | $17.84M | $18.25M | $15.69M |
| Gross Margin? | +69.5% | +67.7% | +65.2% | +65.7% | +62.0% | +57.5% | +65.1% | +68.6% | +72.5% | +75.7% |
| Operating Expenses? | $113.85M | $99.98M | $81.35M | $97.99M | $80.30M | $76.93M | $91.63M | $59.62M | $54.74M | $40.74M |
| Operating Income? | -$85.90M | -$75.45M | -$61.17M | -$78.94M | -$65.25M | -$63.59M | -$74.30M | -$41.78M | -$36.49M | -$25.05M |
| EBITDA? | -$83.40M | -$70.91M | -$57.96M | -$76.49M | -$58.60M | -$62.06M | -$71.06M | -$41.04M | -$36.53M | -$24.48M |
| Income Before Tax | -$87.44M | -$73.74M | -$61.21M | -$81.55M | -$63.84M | -$66.83M | -$74.25M | -$41.62M | -$37.06M | -$24.90M |
| Income Tax Expense | -$5.51M | -$5.50M | -$4.88M | -$5.62M | -$6.73M | -$5.27M | -$4.61M | -$3.57M | -$4.82M | -$2.10M |
| Net Income? | -$81.93M | -$68.24M | -$56.33M | -$75.92M | -$57.11M | -$61.56M | -$69.64M | -$38.05M | -$32.24M | -$22.80M |
| EPS? | $-0.15 | $-0.17 | $-0.16 | $-0.23 | $-0.21 | $-0.29 | $-0.27 | $-0.19 | $-0.18 | $-0.14 |
| Diluted EPS? | $-0.15 | $-0.17 | $-0.16 | $-0.23 | $-0.21 | $-0.29 | $-0.27 | $-0.19 | $-0.18 | $-0.14 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality